Opioids. Biometrics. Forever chemicals. Corporate America is under attack from new liabilities and is looking to its insurance companies for assistance. However, the basic response by the insurance industry is to deny coverage. This session will examine case law from the first half of 2023 on each of these new liabilities, along with cases on other key issues such as the expected/intended exclusion, allocation, reservation of rights letters, and concurrent causation. This session provides essential insights and analysis for any company seeking insurance coverage.